Extracellular HMGB1 promotes the release of cytokines, such as IL-6 and IL-8, through activation of the MAPK- and MyD88-dependent NF-κB pathways, which stimulates the proliferation, angiogenesis, EMT, invasion, and metastasis of tumor cells. This evidence concerns the gene HMGB1 and neoplasm.